| Literature DB >> 28005928 |
Tony Blakely, Linda J Cobiac, Christine L Cleghorn, Amber L Pearson, Frederieke S van der Deen, Giorgi Kvizhinadze, Nhung Nghiem, Melissa McLeod, Nick Wilson.
Abstract
[This corrects the article DOI: 10.1371/journal.pmed.1001856.].Entities:
Year: 2016 PMID: 28005928 PMCID: PMC5179055 DOI: 10.1371/journal.pmed.1002211
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Fig 1Future smoking prevalence in the New Zealand 2011 population by scenario and QALY gains between scenarios.
QALYs gained for areas between the curves A, B, and C are undiscounted. QALYs discounted at 3% are (A) 655,000, (B) 58,000, and (C) 391,000. “Smoking cessation stops, initiation continues” = scenario of no further net smoking cessation among those already smoking in 2011, ongoing initiation of people aged up to 20 y of age in 2011. The prevalence therefore increases up to 2031 in this closed cohort (due to new smokers outnumbering differential deaths by smoking status), then declines over time because of aging of the population and the higher mortality rate of smokers. BAU = scenario of net cessation and initiation rate trends observed between 2006 and 2013 censuses continuing into the future (tax effects removed), including differential mortality from smoking (i.e., additionally allowing for higher mortality of current (and ex-) smokers that will also decrease prevalence).
Fig 5Projected percentage changes in ethnic inequalities in all-cause mortality rates for 10% increases in tobacco tax per annum from 2011 to 2031—Standardized rate ratios (SRR; percentage change in “excess” SRR or SRR-1).
Rates are standardized to the WHO world population.